Trial · NCT00808067
Outcomes14
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Major Bleeding, Annualized Rate of Subjects With Major Bleeds | up to 43 months | SAF-FAS interval | percentage of subject-years | NUMBER |
| SECONDARY | Stroke, Annualized Rate of Subjects With Stroke | up to 43 months | SAF-FAS interval | percentage of subject-years | NUMBER |
| SECONDARY | Non CNS Systemic Embolism (SEE), Annualized Rate of Subjects With Non-CNS SEE | up to 43 months | SAF-FAS interval | percentage of subject-years | NUMBER |
| SECONDARY | Pulmonary Embolism (PE), Annualized Rate of Subjects With PE | up to 43 months | SAF-FAS interval | percentage of subject-years | NUMBER |
| SECONDARY | Acute Myocardial Infarction (MI), Annualized Rate of Subjects With MI | up to 43 months | SAF-FAS interval | percentage of subject-years | NUMBER |
| SECONDARY | Deep Vein Thrombosis, Annualized Rate of Subjects With DVT | up to 43 months | SAF-FAS interval | percentage of subject-years | NUMBER |
| SECONDARY | Death, Annualized Rate of Subject Death | up to 43 months | SAF-FAS interval | percentage of subject-years | NUMBER |
| SECONDARY | Annualized Rate of Subjects With Composite Incidence of Stroke, Non CNS Systemic Embolism (SEE) | up to 43 months | SAF-FAS interval | percentage of subject-years | NUMBER |
| SECONDARY | Annualized Rate of Subjects With Composite Incidence of Stroke, Non CNS Systemic Embolism (SEE) and All Cause Death | up to 43 months | SAF-FAS interval | percentage of subject-years | NUMBER |
| SECONDARY | Annualized Rate of Subjects With Composite Incidence of Stroke, Non CNS Systemic Embolism (SEE), Pulmonary Embolism (PE), Myocardial Infarction, Vascular Death | up to 43 months | SAF-FAS interval | percentage of subject-years | NUMBER |
| SECONDARY | Annualized Rate of Subjects With Composite Incidence of Stroke, Non CNS Systemic Embolism (SEE), Pulmonary Embolism (PE), Myocardial Infarction (MI), All Cause Death and Major Bleed | up to 43 months | SAF-FAS interval | percentage of subject-years | NUMBER |
| SECONDARY | Annualized Rate of Subjects With Minor Bleeds | up to 43 months | SAF-FAS interval | percentage of subject-years | NUMBER |
| SECONDARY | Annualized Rate of Subjects With Any Bleeds (Major Plus Minor) | up to 43 months | SAF-FAS interval | percentage of subject-years | NUMBER |
| SECONDARY | Annualized Rate of Subjects With Intra-Cranial Hemorrhage (ICH) | up to 43 months | SAF-FAS interval | percentage of subject-years | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00808067/outcomes